Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002539231 | SCV001019323 | likely benign | Bethlem myopathy 1A | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004530855 | SCV004117675 | uncertain significance | COL6A2-related disorder | 2022-08-25 | criteria provided, single submitter | clinical testing | The COL6A2 c.522G>A variant is not predicted to result in an amino acid change (p.=). This variant is predicted to possibly alter splicing based on available splicing prediction programs (Alamut Visual v2.11). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0089% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/21-47532299-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |